Germany Daily Briefing

IFNNY (Infineon Technologies ADR) gained 8.72% in a move that mirrors the global semiconductor repricing driven by Intel's foundry narrative and NVDA's sustained AI accelerator demand. Infineon's product exposure — power semiconductors, automotive chips, and industrial control ICs — overlaps with AI infrastructure at the power management and edge-compute layer, making it a European proxy for the AI hardware investment cycle. The +8.72% move on no Infineon-specific news confirms this was systemic AI semiconductor repricing rather than a company event. SIEGY (Siemens Energy) +1.34% also benefited — Siemens Energy's grid infrastructure business is a second-order AI beneficiary as data centre power demand drives grid investment. Adidas +3.12% was the consumer-brand standout, decoupling from the broader auto-sector China anxiety on the strength of its North America and India market narrative.

MBGAF (Mercedes-Benz Group ADR) fell 3.89% — the session's worst individual large-cap performance and a continuation of the China luxury auto demand deterioration that has weighed on the stock since Q2 delivery guidance was revised lower. The China luxury vehicle market, which accounts for approximately 30% of Mercedes-Benz's global sales volume, has been showing persistent weakness as Chinese consumers prioritise domestic EV brands over imported luxury vehicles. BMW (BMWYY, proxied by BFFAF -2.90%) traded in sympathy. The DAX auto-sector -2.39% aggregate masks even steeper individual moves in the ADR complex. This is the China end-market story that Eva has been flagging for three weeks: until Chinese property sector stabilises and consumer confidence recovers, the DAX auto pair faces a structural earnings headwind that no ECB rate cut alone can offset.

BASFY (BASF ADR) -2.36% continues to price in what the chemicals sector has known for twelve months: China's industrial demand for chemical inputs — from plastics precursors to specialty additives — is not recovering to pre-2022 levels in a straight line. FAZ Finanzen's weekend coverage of the broader German export-sector story reinforces the narrative. BASF's Ludwigshafen restructuring plan (cutting 2,600 jobs in Europe, expanding China-local-for-local production) is the management response — but the market has concluded that local-for-local in China means lower European factory utilisation, not revenue recovery. Chemicals/Pharma sector -1.87% confirms this is not single-stock noise. The Energiewende is an additional cost-side pressure: German industrial electricity prices remain elevated relative to US and Asian peers, compressing export-goods competitiveness at a time when China demand is structurally softer.